TSND Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
TerrAscend Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.76 |
52 Week High | CA$3.21 |
52 Week Low | CA$1.57 |
Beta | 1.91 |
11 Month Change | -7.85% |
3 Month Change | -23.14% |
1 Year Change | -9.74% |
33 Year Change | -83.46% |
5 Year Change | -72.71% |
Change since IPO | 45.45% |
Recent News & Updates
Recent updates
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Apr 25What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
Mar 10Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
Jan 24Is TerrAscend (TSE:TSND) A Risky Investment?
Dec 25TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
Aug 13TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
Jul 03TerrAscend (CSE:TER) Is Making Moderate Use Of Debt
Mar 06Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?
Dec 21Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates
Aug 14Is TerrAscend (CSE:TER) Using Too Much Debt?
Jul 15Is TerrAscend (CSE:TER) Using Too Much Debt?
Nov 03Shareholder Returns
TSND | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | -5.9% | -1.2% | -0.3% |
1Y | -9.7% | 39.8% | 10.1% |
Return vs Industry: TSND underperformed the Canadian Pharmaceuticals industry which returned 36.7% over the past year.
Return vs Market: TSND underperformed the Canadian Market which returned 10.2% over the past year.
Price Volatility
TSND volatility | |
---|---|
TSND Average Weekly Movement | 12.8% |
Pharmaceuticals Industry Average Movement | 12.4% |
Market Average Movement | 8.1% |
10% most volatile stocks in CA Market | 16.7% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: TSND's share price has been volatile over the past 3 months.
Volatility Over Time: TSND's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
TSND fundamental statistics | |
---|---|
Market cap | CA$617.81m |
Earnings (TTM) | -CA$119.18m |
Revenue (TTM) | CA$451.16m |
1.1x
P/S Ratio-4.2x
P/E RatioIs TSND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TSND income statement (TTM) | |
---|---|
Revenue | US$328.56m |
Cost of Revenue | US$164.03m |
Gross Profit | US$164.53m |
Other Expenses | US$251.32m |
Earnings | -US$86.79m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 08, 2024
Earnings per share (EPS) | -0.30 |
Gross Margin | 50.08% |
Net Profit Margin | -26.42% |
Debt/Equity Ratio | 86.1% |
How did TSND perform over the long term?
See historical performance and comparison